Eyexora aims to accelerate ophthalmology development by centralising expertise

Claiming the title of the first ophthalmology-focused company with a hub-and-spoke business model, Eyexora debuted on Wednesday with seed funding from ClavystBio to build a global portfolio of devices, as well as anterior and posterior segment therapeutics.